Navigation Links
Neptune Technologies receives GRAS notification in the United States
Date:1/23/2008

a required milestone for functional food partners and market entrance

LAVAL, QC, Jan. 23 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) received notification that Neptune Krill Oil ("NKO(R)") has been determined to be safe as a human food ingredient, a regulatory status required for the commercialization of NKO(R) incorporated into different functional foods. Neptune has completed all the necessary regulatory clearances for full commercialization in the United States.

A three-member panel of independent experts, Richard C. Kraska, Ph.D., DABT, Robert S. McQuate, Ph.D. and Stanley T. Omaye, Ph.D., with backgrounds in toxicology, chemistry and pharmacology, performed an independent safety evaluation of NKO(R). The review included an extensive package of safety, toxicology and clinical research data obtained from animal and human testing. In addition, information relating to the historic use of NKO(R) in food, compositional details, specifications and method of preparation was submitted.

Dr. McQuate, CEO of GRAS Associates, indicated that the safety dossier that has been generated by Neptune is impressive in its scientific rigor and attention to critical details. The compositional characterization of the proprietary krill oil is most impressive, and the analytical data were carefully compared with other commonly consumed fish oils that are known to be safe for human consumption. He added that additional support for NKO(R)'s GRAS determination under the anticipated conditions of use was derived from accompanying clinical and animal safety testing.

"Achieving GRAS notification within the target timeframe fulfills one more milestone in Neptune's development program as well as a major requirement of our partners in the food industry, Nestle and Yoplait. GRAS approval is another step leading to the commercialization of NKO(R) in the functional and medical food markets," said Dr. Tin
'/>"/>

SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results
2. Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update
3. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
4. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
5. Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R)
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
8. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
9. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
10. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
11. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... LONDON , December 23, 2014 ... Review Algeria , out today and available for free ... the actors driving change and growth in the sector today. ... has scored notable successes has been in developing a homegrown ... 70 percent local production still remains some way off. A ...
(Date:12/22/2014)... ROCKVILLE, Md. , Dec. 22, 2014 ... MKT: SYN), a developer of pathogen-specific therapies ... focus on protecting the microbiome, today announced ... a Phase 1a clinical trial of SYN-004, ... the prevention of Clostridium difficile (C. ...
(Date:12/22/2014)... 2014 The American Journal ... original research, reviews and editorials addressing developments and ... today published a provocative article exploring the role ... and potential treatment of prostate cancer. , ... proposes the possibility that there could be a ...
(Date:12/19/2014)... 19, 2014 BioPlus Specialty Pharmacy ... announces the promotion of Nick Maroulis, Pharm.D. to the ... Services. , In this position, Dr. Maroulis will ... managing the directors of our multi-site pharmacies as the ... 1997 and during that time he has served in ...
Breaking Biology Technology:PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... CAMBRIDGE, England, October 12 Crescendo Biologics,("Crescendo") today ... to advance the development of its fragment antibody technology,platforms. ... Paris-based,venture capital firm, with Aitua, Avlar BioVentures and the ... Crescendo brings together highly innovative in vivo and in ...
... , SAN FRANCISCO, Oct. 12 Dr. Michael ... implant inventor, brain plasticity expert and ... Medicine (IOM) today in Washington, D.C. Also a member of ... a small group of scientists and doctors in the U.S. ...
... ANA, Calif., Oct. 12 Selexis SA ("Selexis") and ... present results of a recent collaborative effort combining the ... IS CHO Culture System, demonstrating the rapid production of ... cell lines. Irvine and Selexis will jointly present ...
Cached Biology Technology:Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners 2Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners 3Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners 4Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research 2Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research 3Irvine Scientific and Selexis to Announce Results of Successful Collaboration 2
(Date:12/22/2014)... , Dec. 22, 2014  The 2014 ... the biometrics industry as Acuity Market Intelligence reports ... may finally be open. Acuity forecasts that intensifying ... devices that incorporate biometrics will drive a global ... billion biometric devices by 2020.   ...
(Date:12/19/2014)... VIEW, Calif. , Dec. 18, 2014  23andMe, ... publication of a study that pinpoints fine-scale differences in ... United States . Since immigrants first ... the United States has served as a ... illuminates how American history and the ongoing mixing of ...
(Date:12/17/2014)... , Dec. 15, 2014 The Defense ... it easier to detect and prevent counterfeit microcircuits ... Today the agency started performing an in-house microcircuit ... validate the authenticity of purchased microcircuits while increasing ... quality control measures will be conducted at DLA,s ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3
... grow beyond a limited size without an adequate blood ... researchers have sought to understand how a tumor,s vascular ... developing: If the vascular network never develops, the ... at the University of Massachusetts Medical School have discovered ...
... want, to paraphrase the Rolling Stones, but sometimes they can ... appear in the May issue of the American Naturalist ... of evolutionary changes in life on earth as well as ... yet the amount of variability seen among successive fossil assemblages ...
... of spaceflight will be used to examine how cells ... face of stress or damage. At 3:21 ... Cheryl Nickerson and her team, including Jennifer Barrila and ... low earth orbit aboard the space shuttle Discovery on ...
Cached Biology News:UMMS researchers uncover novel genetic pathway responsible for triggering vascular growth 2Ecologists receive mixed news from fossil record 2Out of this world: New study investigates infection of human cells in space 2Out of this world: New study investigates infection of human cells in space 3Out of this world: New study investigates infection of human cells in space 4
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
... modified nucleotide structure called a ?cap? ... most naturally-occurring eukaryotic mRNAs and many ... for a portion of the GTP ... reaction results in the synthesis of ...
Improve inventory management with stainless steel red cell canisters; ensure product safety with CO2 or LN2 backup systems. A complete solution for your blood banking needs....
This Dedicated 18" X 18" (45.7 X 45.7 cm.) shaker platforms are optimized for a particular flask clip size. Dedicated platforms come fully loaded with flask clips....
Biology Products: